A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
about
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortN-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancerTranscriptome sequencing to detect gene fusions in cancerRecurrent rearrangements in prostate cancer: causes and therapeutic potentialDiscovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate TissueOverexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastasesEmergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumoursThe Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathwaysSLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancerDeep sequencing reveals distinct patterns of DNA methylation in prostate cancer.Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell linesRearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaAntibody-based detection of ERG rearrangement-positive prostate cancerNovel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.The ETS family of oncogenic transcription factors in solid tumours.Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells.ERG rearrangement is associated with prostate cancer-related death in Chinese prostate cancer patientsAndrogen receptor-driven chromatin looping in prostate cancer.Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contextsOverexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transitionDifferences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.Landscape of gene fusions in epithelial cancers: seq and ye shall find.Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.Common gene rearrangements in prostate cancerETS rearrangements in prostate cancerComprehensive Analysis of ETS Family Members in Melanoma by Fluorescence In Situ Hybridization Reveals Recurrent ETV1 Amplification.MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discoveryEarly detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel of TMPRSS2:ETS fusion gene markersChimeric transcript discovery by paired-end transcriptome sequencingTranslocations in epithelial cancers.Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.Urine markers in monitoring for prostate cancer.Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination SystemThe complexity of prostate cancer: genomic alterations and heterogeneity.TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer ProgressionRecurrent gene fusions in prostate cancer: their clinical implications and uses.
P2860
Q24606772-05FE3019-4E12-4348-9370-FC242899EFE5Q24647034-33898894-1909-403C-BEAF-75E0B62C77A9Q24653386-0D132A0A-06A2-494D-A4E4-8AEEC13B94DCQ26851525-88DE0399-BECD-4B91-A8B2-A1EFC87D9112Q26997884-07292767-9DFF-4DA6-A739-AA679FA6D9BEQ27853114-443FECC2-8916-41F7-9784-1CDFDF09CBEBQ28247245-7210FEA2-8947-4F1D-86FD-97CEC9A0BBF2Q28609639-E90D7148-F119-4D96-A204-28D161123E37Q28854594-7A95DEA5-041C-4CAA-8030-5B6B9D7A52D3Q33777675-771D6F99-793E-4B3B-9743-2EF1E4154B41Q33949373-BC5D225A-2F3E-43FA-A7E9-042829C59D97Q33988757-3D5BEDB4-81E2-4EB4-B23A-5F44AAE0C4B7Q33992803-15024B87-AC92-40B8-B915-4FB28BB9374CQ34009867-C3BD3254-8929-4EA9-8A30-27B6B56F7818Q34158217-EBFA8463-617E-4A4B-AEEB-4DA7753A5A91Q34555986-D0B3D2DD-B5B5-418F-96B6-62F7D0282C6BQ34580034-596D437C-2713-4E7D-B6CA-BA8D894A644BQ34613397-E21D903C-C35A-4D6B-A47B-9FCDF8613F22Q35091321-CC6D7806-4169-459A-A72C-95D44604AB75Q35589706-1F1D6150-4E78-41C5-97E6-B5C04E371E25Q35741647-31CDCA92-F908-4B69-8249-50C4DC78416FQ36143137-0A6460F2-5699-457A-9650-E5E51B3F8DB7Q36291246-EDD4325E-1726-4504-8BB7-F8A2D98BA238Q36383369-E95C15DF-9B7C-4D22-8AE3-D7C2C5372B69Q36901964-20308480-E4A7-41D7-9B42-D0BD3B34B3D4Q36920169-3DB2AB98-F9D8-4E8D-9A2E-B0361C7827A4Q37047029-0DC5458D-919B-4BFA-8188-62D81B4881A2Q37060942-28448C24-7734-4C03-8524-E245A76FF9CEQ37113174-5F5EA170-F448-43D9-A9E6-32BCD9ACBFD7Q37231977-7AED4DC6-4DE2-4FD6-909A-6AC35AD227FBQ37257656-ED3C3A01-2FB4-4502-A061-1447ADEC4683Q37363960-1930E511-4C8F-4510-A400-7682A3877CAAQ37383449-CC3A4899-B482-4DEE-B556-493EBF9322F5Q37383459-BFD4E5CD-CE5E-4EDA-B44D-75E53F066B78Q37460447-799229FF-725A-4603-A7F7-F722FDE1990EQ37571461-CB40E197-23E4-4CAE-8214-59E41638D9C5Q37611723-8923CFF6-DF6A-4B18-B6F5-ED344421BDD2Q38058243-732ABDD1-8C50-46E2-B752-880EC057DCD4Q38069582-F95CCA7D-5127-4821-B53B-0EE4841B1D1AQ38102618-CF3DF4A1-8A7D-4455-87ED-803424F65C84
P2860
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A fluorescence in situ hybridi ...... on protein in prostate cancer.
@en
A fluorescence in situ hybridi ...... on protein in prostate cancer.
@nl
type
label
A fluorescence in situ hybridi ...... on protein in prostate cancer.
@en
A fluorescence in situ hybridi ...... on protein in prostate cancer.
@nl
prefLabel
A fluorescence in situ hybridi ...... on protein in prostate cancer.
@en
A fluorescence in situ hybridi ...... on protein in prostate cancer.
@nl
P2093
P2860
P50
P1433
P1476
A fluorescence in situ hybridi ...... on protein in prostate cancer.
@en
P2093
Anjana Menon
Arul M Chinnaiyan
Bharathi Laxman
Rajal B Shah
Robert J Lonigro
Rohit Mehra
Saravana M Dhanasekaran
P2860
P304
P356
10.1158/0008-5472.CAN-08-2014
P407
P577
2008-09-01T00:00:00Z